Skip to main content
Caplight Logo









Biolumo Sp. z o.o.

Biolumo Sp. z o.o.

Private
GdyniaHealthcare & Life Scienceshttps://biolumo.eu/

Last Round

Grant

Jul 28, 2018

Est. Valuation

$295,000

Total Funding Raised

$27,100

Company Overview

Biolumo Sp. z o.o. is a MedTech company that develops point-of-care diagnostic devices designed to provide rapid antibiotic susceptibility testing to help healthcare providers prescribe precise antibiotic treatments.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

antibiotic susceptibility testingASTpoint-of-care diagnosticsmedical devicerapid diagnosticsantibiotic stewardshipbacterial infection testingclinical laboratory equipmentdiagnostic cartridgesmedtechlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biolumo Sp. z o.o. Comparables

Compare Biolumo Sp. z o.o. with similar companies based on industry and business-model similarity.

Biolumo Sp. z o.o. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FASTinov
86%
Resistell AG
84%
Gradientech
83%

Biolumo Sp. z o.o. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 28, 2018
AcceleratorDec 15, 2017

Biolumo Sp. z o.o. Investors

Notable investors and investment history

Biolumo Sp. z o.o. investors
InvestorRounds
StartupbootcampAccelerator
EIT Health InnoStars AwardsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 27, 2024

    Monthly visitors grew 33% MoM, from 27 to 36.

  • Dec 15, 2017

    $18K raised in an accelerator round

Biolumo Sp. z o.o. Filings

Explore SEC and related filing metadata, where available.

Biolumo Sp. z o.o. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biolumo Sp. z o.o.'s valuation, stock price, and market status.

Is Biolumo Sp. z o.o. a public or private company?

Biolumo Sp. z o.o. is a private company.

What is the current stock price of Biolumo Sp. z o.o.?

Biolumo Sp. z o.o. is a private company, so its shares have no public market price. Caplight tracks Biolumo Sp. z o.o.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Biolumo Sp. z o.o. worth (valuation)?

Biolumo Sp. z o.o.'s valuation is estimated at $295.0K based on funding round data.

Can I buy Biolumo Sp. z o.o. stock?

Biolumo Sp. z o.o. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Biolumo Sp. z o.o.'s last funding round?

Biolumo Sp. z o.o.'s most recent funding round was Grant on July 28, 2018.

Who are the main investors in Biolumo Sp. z o.o.?

Key investors in Biolumo Sp. z o.o. include Startupbootcamp, EIT Health InnoStars Awards.

Will Biolumo Sp. z o.o. IPO soon?

No public IPO plans have been announced for Biolumo Sp. z o.o..

How can I track Biolumo Sp. z o.o. secondary market activity?

Caplight tracks bids, offers, and trades in Biolumo Sp. z o.o.'s shares on secondary markets.

Firmographic Details

HeadquartersGdynia
Year Founded2017
Last FundingJul 28, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?